|
|
Volumn 34, Issue 1, 2002, Pages 73-74
|
|
Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
CYTOMEGALOVIRUS ANTIBODY;
GANCICLOVIR;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
FEMALE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION PREVENTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MALE;
MORBIDITY;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
RECIPIENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
VIRUS REACTIVATION;
ADULT;
AGED;
ANTIBODIES, VIRAL;
ANTILYMPHOCYTE SERUM;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
FEMALE;
GANCICLOVIR;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
|
|
EID: 0036226409
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02671-9 Document Type: Article |
|
Times cited : (7)
|
|
References (6)
|
